Literature DB >> 28179169

Vertebral bone marrow fat, bone mineral density and diabetes: The Osteoporotic Fractures in Men (MrOS) study.

Yahtyng Sheu1, Francesca Amati2, Ann V Schwartz3, Michelle E Danielson4, Xiaojuan Li5, Robert Boudreau6, Jane A Cauley7.   

Abstract

Elevated vertebral bone marrow fat (BMF) among individuals with osteoporosis has been established in histomorphometric studies. Several studies have found a negative correlation between BMF and bone mineral density (BMD) at the spine in men and women across different age groups. Animal studies have also observed bone loss with increased BMF in mice with induced diabetes. Our study objective was to test the hypothesis that the association between BMF and BMD varies by diabetic status. We performed a cross-sectional study of 156 men aged 74-96years from the Osteoporotic Fractures in Men study at the Pittsburgh clinical site. All men had spine BMF scans using proton magnetic resonance spectroscopy and spine and hip BMD scans by dual-energy X-ray absorptiometry. BMF was expressed as lipid to "lipid+water" ratio (%). Men were considered diabetic if they self-reported a physician diagnosis of diabetes, diabetes medication or had a fasting glucose ≥126mg/dl. Men with diabetes (n=38) had a significantly higher spine BMF (58.9 vs. 54.6%, p=0.0035), spine BMD (1.20 vs. 1.10g/cm2, P=0.007) and total hip BMD (1.00 vs. 0.94g/cm2, p=0.04) than those without, while no differences were observed for body weight, body mass index or waist circumference. Pearson correlation tests showed no significant correlation of spine BMF with age or BMD in non-diabetics. Significant inverse correlations were observed between BMF and BMD (-0.30 for femoral neck and -0.39 for total hip) among diabetic men. In conclusion, men with diabetes had a higher BMF compared to non-diabetic men. The correlation between BMF and BMD differed by diabetes status. Further investigation of the association of diabetes with BMF and BMD may provide a better understanding of the high fracture rates among individuals with diabetes despite their higher BMD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone-fat interactions; DXA; General population studies

Mesh:

Year:  2017        PMID: 28179169      PMCID: PMC5367972          DOI: 10.1016/j.bone.2017.02.001

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  48 in total

Review 1.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Clinical review 94: What's in a name? In search of leptin's physiologic role.

Authors:  J S Flier
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

3.  Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study.

Authors:  Lauren A Weiss; Elizabeth Barrett-Connor; Denise von Mühlen; Patricia Clark
Journal:  J Bone Miner Res       Date:  2006-05       Impact factor: 6.741

4.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

Authors:  Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

5.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

6.  Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men.

Authors:  Mattias Lorentzon; Kerstin Landin; Dan Mellström; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

7.  Human bone marrow adiposity is linked with serum lipid levels not T1-diabetes.

Authors:  Jill M Slade; Lindsay M Coe; Ron A Meyer; Laura R McCabe
Journal:  J Diabetes Complications       Date:  2012-01-17       Impact factor: 2.852

8.  Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study.

Authors:  A L Schafer; X Li; A V Schwartz; L S Tufts; A L Wheeler; C Grunfeld; L Stewart; S J Rogers; J T Carter; A M Posselt; D M Black; D M Shoback
Journal:  Bone       Date:  2015-01-17       Impact factor: 4.398

Review 9.  Diabetes mellitus, bone mineral density, and fracture risk.

Authors:  Elsa S Strotmeyer; Jane A Cauley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2007-12       Impact factor: 3.243

10.  Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures.

Authors:  Janina M Patsch; Xiaojuan Li; Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Ann V Schwartz; Thomas M Link
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

View more
  19 in total

1.  Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.

Authors:  H Zhou; C Li; W Song; M Wei; Y Cui; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2021-01-06       Impact factor: 4.507

Review 2.  Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus.

Authors:  Sundeep Khosla; Parinya Samakkarnthai; David G Monroe; Joshua N Farr
Journal:  Nat Rev Endocrinol       Date:  2021-09-13       Impact factor: 47.564

3.  Bone marrow adipose tissue composition and glycemic improvements after gastric bypass surgery.

Authors:  Tiffany Y Kim; Ann V Schwartz; Xiaojuan Li; Kaipin Xu; Galateia J Kazakia; Carl Grunfeld; Robert A Nissenson; Dolores M Shoback; Anne L Schafer
Journal:  Bone Rep       Date:  2022-06-06

4.  Saturated and Unsaturated Bone Marrow Lipids Have Distinct Effects on Bone Density and Fracture Risk in Older Adults.

Authors:  Gina N Woods; Susan K Ewing; Anne L Schafer; Vilmundur Gudnason; Sigurdur Sigurdsson; Thomas Lang; Trisha F Hue; Deborah M Kado; Eric Vittinghoff; Clifford Rosen; Xiaojuan Li; Ann V Schwartz
Journal:  J Bone Miner Res       Date:  2022-01-31       Impact factor: 6.390

Review 5.  Clinical implications of bone marrow adiposity.

Authors:  A G Veldhuis-Vlug; C J Rosen
Journal:  J Intern Med       Date:  2018-01-15       Impact factor: 8.989

6.  Deletion of Rptor in Preosteoblasts Reveals a Role for the Mammalian Target of Rapamycin Complex 1 (mTORC1) Complex in Dietary-Induced Changes to Bone Mass and Glucose Homeostasis in Female Mice.

Authors:  Pawanrat Tangseefa; Sally K Martin; Agnieszka Arthur; Vasilios Panagopoulos; Amanda J Page; Gary A Wittert; Christopher G Proud; Stephen Fitter; Andrew C W Zannettino
Journal:  JBMR Plus       Date:  2021-03-24

7.  Bone marrow adipose tissue content in Latino adolescents with prediabetes and obesity.

Authors:  Kiley B Vander Wyst; Houchun H Hu; Armando Peña; Micah L Olson; Smita S Bailey; Gabriel Q Shaibi
Journal:  Obesity (Silver Spring)       Date:  2021-09-28       Impact factor: 5.002

Review 8.  Quantitative MRI and spectroscopy of bone marrow.

Authors:  Dimitrios C Karampinos; Stefan Ruschke; Michael Dieckmeyer; Maximilian Diefenbach; Daniela Franz; Alexandra S Gersing; Roland Krug; Thomas Baum
Journal:  J Magn Reson Imaging       Date:  2017-06-01       Impact factor: 4.813

Review 9.  Molecular Interaction of Bone Marrow Adipose Tissue with Energy Metabolism.

Authors:  Karla J Suchacki; William P Cawthorn
Journal:  Curr Mol Biol Rep       Date:  2018-04-28

10.  Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population.

Authors:  Yuhua Wen; Huijuan Li; Xiaoya Zhang; Peipei Liu; Jing Ma; Liya Zhang; Keqin Zhang; Lige Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.